PAVmed (PAVM) Share-based Compensation (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -353.26% |
| Sep 30, 2025 | 136.42% |
| Jun 30, 2025 | -82.58% |
| Mar 31, 2025 | 26.88% |
| Jun 30, 2024 | 1.17% |
| Mar 31, 2024 | -4.37% |
| Dec 31, 2023 | -12.34% |
| Sep 30, 2023 | -10.45% |
| Jun 30, 2023 | -43.27% |
| Mar 31, 2023 | -10.71% |
| Dec 31, 2022 | 3.88% |
| Sep 30, 2022 | -4.85% |
| Jun 30, 2022 | 4.01% |
| Mar 31, 2022 | 9.91% |
| Dec 31, 2021 | 9.77% |
| Sep 30, 2021 | -23.31% |
| Jun 30, 2021 | 262.33% |
| Mar 31, 2021 | 145.05% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 10.78% |
| Jun 30, 2020 | 53.78% |
| Mar 31, 2020 | -12.69% |
| Dec 31, 2019 | 19.39% |
| Sep 30, 2019 | -14.95% |
| Jun 30, 2019 | -15.47% |
| Mar 31, 2019 | 39.49% |
| Dec 31, 2018 | 1.41% |
| Sep 30, 2018 | 6.77% |
| Jun 30, 2018 | 12.02% |
| Mar 31, 2018 | 9.02% |
| Dec 31, 2017 | -8.61% |
| Sep 30, 2017 | 7.08% |
| Jun 30, 2017 | -6.74% |
| Mar 31, 2017 | 10.07% |
| Dec 31, 2016 | -23.30% |